# Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

> **NCT01447576** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 1036 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ADT
- **DRUG:** OPC-34712

## Key facts

- **NCT ID:** NCT01447576
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 1036 (ACTUAL)
- **Last updated:** 2015-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447576, "Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01447576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*